Trinity Biotech
TRIB
#9739
Rank
C$31.6 M
Marketcap
$1.15
Share price
5.12%
Change (1 day)
-61.57%
Change (1 year)

P/E ratio for Trinity Biotech (TRIB)

P/E ratio as of December 2024 (TTM): -0.9900

According to Trinity Biotech 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.989975. At the end of 2022 the company had a P/E ratio of -3.86.

P/E ratio history for Trinity Biotech from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-3.86-102.29%
2021169-369.46%
2020-62.61586.44%
2019-3.71-65.74%
2018-10.8-18.82%
2017-13.370.5%
2016-7.83-112.46%
201562.8-45.75%
2014116-59.28%
2013284226.99%
201287.026.31%
201168.9344.26%
201015.5-57.03%
200936.1-1573.52%
2008-2.45-90.55%
2007-25.9-112.33%
2006210202.72%
200569.486.22%
200437.3-31.46%
200354.4286.59%
200214.1-77.06%
200161.3

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
6.27-733.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-57.7 5,733.39%๐Ÿ‡บ๐Ÿ‡ธ USA
38.5-3,989.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.3792-61.70%๐Ÿ‡บ๐Ÿ‡ธ USA
228-23,146.04%๐Ÿ‡บ๐Ÿ‡ธ USA
34.1-3,546.95%๐Ÿ‡บ๐Ÿ‡ธ USA
28.7-3,002.79%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.